Cart
sales@molnova.com
FGF22-IN-1
CAS No. 113143-13-8
FGF22-IN-1( —— )
Catalog No. M36498 CAS No. 113143-13-8
FGF22-IN-1 is a potential CD4 N-terminal immunoglobulin variable region-like domain (CD4 D1) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 101 | In Stock |
|
| 10MG | 163 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 500 | In Stock |
|
| 100MG | 712 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1442 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFGF22-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionFGF22-IN-1 is a potential CD4 N-terminal immunoglobulin variable region-like domain (CD4 D1) inhibitor.
-
DescriptionFGF22-IN-1 (compound c1) is a potent CD4 D1 inhibitor. FGF22-IN-1 can be used as immunosuppressive agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number113143-13-8
-
Formula Weight269.32
-
Molecular FormulaC14H11N3OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (371.31 mM; Ultrasonic )
-
SMILESO=C(NN=CC1=CNC=2C=CC=CC12)C=3SC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xiao H, et al. Potent inhibition of the CD4-dependent T cell response by J2, a novel nonpeptide organic ligand of CD4 D1. Mol Immunol. 2007 Feb;44(5):784-95.?
molnova catalog
related products
-
PH-46A
A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases.
-
Opioid receptor anta...
Acetalin-2 is an opioid peptide with a sequence of Ac-Arg-Phe-Met-Trp-Met-Arg-NH2. Acetalin-2 is selectively bound to [3H]DAMGO with a Ki value of 93.3 nM.
-
GAK inhibitor 49
GAK inhibitor 49 is a highly selective and ATP-competitive cyclin G associated kinase (GAK) inhibitor (IC50: 56 nM; Ki: 0.54 nM ).
